Cozen O’Connor: Eurofins Scientific Acquires EAG Laboratories for $780 Million

Eurofins Scientific Acquires EAG Laboratories for $780 Million

Tuesday, December 5, 2017

Minneapolis, December 5, 2017 – The national corporate practice and international practice at Cozen O’Connor represented Eurofins Scientific SE in the acquisition of EAG Laboratories from affiliates of Odyssey Investment Partners. The transaction is valued at $780 million on a cash-free, debt-free basis, and closed on December 1, 2017.  

Eurofins Scientific is a world leader in food, environment, and pharmaceuticals products testing and one of the global independent market leaders in testing and laboratory services for agroscience, genomics, and discovery pharmacology, as well as for supporting clinical studies. Eurofins is also a key emerging player in specialty clinical diagnostic testing in Europe and the United States. The company has more than 30,000 employees in 375 laboratories across 41 countries and is listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

EAG serves three main markets: material and engineering sciences, agroscience, and biopharmaceuticals. The acquisition includes EAG’s 21 laboratories in 18 locations around the world, including subsidiaries in the United States and six other countries.

Steven J. Dickinson led the Cozen O’Connor team on the transaction. The team included Barbara Müller, Evan Berquist, Dennis L. Cohen, Heather L. Marx, Jonathan M. Grossman, Jonathan S. Gross, Jay A. Dorsch, Donald J. Kassilke, Richard J. SilpeJoshua C. Weinberger, and Thomas Ingalls. This is the 20th completed acquisition Dickinson and Müller have led for Eurofins.

Cozen O’Connor’s Corporate Practice Group provides sophisticated counsel to a diverse set of businesses and entrepreneurs. The firm’s corporate attorneys assist clients from a wide range of industries in issues related to regulatory compliance, corporate governance, mergers and acquisitions, tax, securities, finance, bankruptcy, and health law. The firm’s M&A attorneys represent Fortune 500 and other multinational companies in acquisitions, and act as lead corporate counsel for small and middle-market businesses. The firm’s international practice represents non-U.S. companies in all aspects of their U.S. acquisitions, joint ventures, and business operations.

About Cozen O’Connor

Established in 1970, Cozen O’Connor has more than 750 attorneys who help clients manage risk and make better business decisions. The firm counsels clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. Representing a broad array of leading global corporations and middle market companies, Cozen O’Connor services its clients’ needs through 26 offices across two continents.

###